Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ian H Harding

Showing results (81-90 of 104) with videos related to

Pageof 11
Sort By:
Brain Communications|October 27, 2025
Plasma phosphorylated tau-217 correlates with brain atrophy, cognition, and cerebrospinal fluid biomarkers in a cognitively healthy community cohortMing Ann Sim, Ella Rowsthorn, William T O'Brien, et al.
BMJ Open|April 14, 2025
STatin TReatment for COVID-19 to Optimise NeuroloGical recovERy (STRONGER): study protocol for a randomised, open label clinical trial in patients with persistent neurological symptoms after COVID-19 infectionCarlos Delfino, Cheryl Carcel, Xiaolei Lin, et al.
Neurology|April 30, 2026
Association of 24-Hour Blood Pressure Variability With Cognition and Brain MRI Markers of Structural Change in Adults in Mid- to Late-LifeMadeline Gibson, Matthew Snelson, Ella Rowsthorn, et al.
Clinical Endocrinology|February 22, 2023
The association between sex hormones and the change in brain-predicted age difference in older womenJo Wrigglesworth, Ian H Harding, Rakibul M Islam, et al.
Geroscience|July 8, 2025
Factor analysis of multimodal MRI, biofluid, and vascular biomarkers reveals latent constructs of brain healthElla Rowsthorn, Ming Ann Sim, William T O'Brien, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 23, 2025
Public HealthStephanie Yiallourou, Madeline Gibson, Emma Louise Palatsides, et al.
BMJ Open|December 17, 2021
Sodium selenate as a disease-modifying treatment for progressive supranuclear palsy: protocol for a phase 2, randomised, double-blind, placebo-controlled trialLucy Vivash, Kelly L Bertram, Charles B Malpas, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|October 29, 2022
Progressive Spinal Cord Degeneration in Friedreich's Ataxia: Results from ENIGMA-AtaxiaThiago J R Rezende, Isaac M Adanyeguh, Filippo Arrigoni, et al.
Biorxiv : the Preprint Server for Biology|September 30, 2024
The Pattern and Staging of Brain Atrophy in Spinocerebellar Ataxia Type 2 (SCA2): MRI Volumetrics from ENIGMA-AtaxiaJason W Robertson, Isaac Adanyeguh, Benjamin Bender, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|February 10, 2025
The Pattern and Stages of Atrophy in Spinocerebellar Ataxia Type 2: Volumetrics from ENIGMA-AtaxiaJason W Robertson, Isaac Adanyeguh, Benjamin Bender, et al.
Pageof 11

Showing results (81-90 of 104) with videos related to

Sort By:
Pageof 11
Brain Communications|October 27, 2025
Plasma phosphorylated tau-217 correlates with brain atrophy, cognition, and cerebrospinal fluid biomarkers in a cognitively healthy community cohortMing Ann Sim, Ella Rowsthorn, William T O'Brien, et al.
BMJ Open|April 14, 2025
STatin TReatment for COVID-19 to Optimise NeuroloGical recovERy (STRONGER): study protocol for a randomised, open label clinical trial in patients with persistent neurological symptoms after COVID-19 infectionCarlos Delfino, Cheryl Carcel, Xiaolei Lin, et al.
Neurology|April 30, 2026
Association of 24-Hour Blood Pressure Variability With Cognition and Brain MRI Markers of Structural Change in Adults in Mid- to Late-LifeMadeline Gibson, Matthew Snelson, Ella Rowsthorn, et al.
Clinical Endocrinology|February 22, 2023
The association between sex hormones and the change in brain-predicted age difference in older womenJo Wrigglesworth, Ian H Harding, Rakibul M Islam, et al.
Geroscience|July 8, 2025
Factor analysis of multimodal MRI, biofluid, and vascular biomarkers reveals latent constructs of brain healthElla Rowsthorn, Ming Ann Sim, William T O'Brien, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 23, 2025
Public HealthStephanie Yiallourou, Madeline Gibson, Emma Louise Palatsides, et al.
BMJ Open|December 17, 2021
Sodium selenate as a disease-modifying treatment for progressive supranuclear palsy: protocol for a phase 2, randomised, double-blind, placebo-controlled trialLucy Vivash, Kelly L Bertram, Charles B Malpas, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|October 29, 2022
Progressive Spinal Cord Degeneration in Friedreich's Ataxia: Results from ENIGMA-AtaxiaThiago J R Rezende, Isaac M Adanyeguh, Filippo Arrigoni, et al.
Biorxiv : the Preprint Server for Biology|September 30, 2024
The Pattern and Staging of Brain Atrophy in Spinocerebellar Ataxia Type 2 (SCA2): MRI Volumetrics from ENIGMA-AtaxiaJason W Robertson, Isaac Adanyeguh, Benjamin Bender, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|February 10, 2025
The Pattern and Stages of Atrophy in Spinocerebellar Ataxia Type 2: Volumetrics from ENIGMA-AtaxiaJason W Robertson, Isaac Adanyeguh, Benjamin Bender, et al.
Pageof 11